Age5 yrs
Real estate1 parcel · 702 m²
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of TIBERONE TECHNOLOGIES is 7.4% (elevated). The 2022 annual accounts show negative equity (€-16k) and a net result of €-16k. Its solvency ranks better than 7% of 1494 sector peers (fiscal year 2022). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone7.4%
Elevated
0%0,5%1,5%4%10%≥25%
Annual accounts: weaker financial profile
+Young company
+Higher-failure-rate region
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Signals
Insufficient current data: the most recent filed accounts (financial year 2022) are too old to derive current signals.
Filing behaviour
From the deposit records, complete market-wideAnnual accounts not filed
The financial year that closed on 31-12-2023 was due at the National Bank by 31-07-2024. Nothing is on record today, 746 days later. 3 financial years are missing in total. Measured on financial year 2023: 41.75% of the companies that did not file are in an abnormal legal state today, against 1.66% of those that did.
Filed more than 90 days late
The financial year that closed on 31-12-2022 was due by 31-07-2023 and was filed on 07-08-2025, 738 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2022, that is 31-07-2023.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | nothing on record | not filed | - |
| 31-12-2023 | 31-07-2024 | nothing on record | not filed | - |
| 31-12-2022 | 31-07-2023 | 07-08-2025 | 738 d late | 2025-00365565 |
| 31-12-2021 | 31-07-2022 | 04-03-2025 | 947 d late | 2025-00042952 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-16k-352.0%
Working capital€-16k-3014.3%
Annual accounts & ratios
Source: NBB · 2022Annual accounts filed on 07-08-2025 with the NBB · fiscal year 2022 · micro
Sector comparison
Fiscal year 2022 · NACE 73, Advertising & market research · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -26.7% | 50.4% | |
| Net result | €-16k | €19k | |
| Equity | €-16k | €34k | |
| Gross operating margin | €-15k | €36k | |
| Total assets | €62k | €79k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€-16k
-352.0%
21-22
€62k
+1954.1%
21-22
€-16k
-3017.4%
21-22
€-16k
-3014.3%
21-22
€78k
+2113.4%
21-22
€78k
+2112.9%
21-22
0.79
-7.2%
21-22
0.79
-7.2%
21-22
Show 4 other metrics
-26.7%
-51.8%
21-22
-4.74
+29.0%
21-22
96.8%
-85.5%
21-22
-25.9%
+78.0%
21-22
Figures by fiscal year
| Fiscal year | 2022 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | - |
| Net profit | €-16k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €62k |
| Equity | €-16k |
| Debt | €78k |
| of which ≤ 1y | €78k |
| of which > 1y | - |
| Working capital | €-16k |
| Employees (FTE) | - |
Ratios (computed)
| 2022 | |
|---|---|
| Current ratio | 0.79 |
| Quick ratio | 0.79 |
| Working capital ratio | -26.7% |
| Solvency | -26.7% |
| Debt / equity | -4.74 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -25.9% |
| ROE | 96.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (17 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €62k |
| Current assets | 29/58 | €62k |
| Amounts receivable within one year | 40/41 | €58k |
| Cash & bank | 54/58 | €3k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €62k |
| Equity | 10/15 | €-16k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €-19k |
| Amounts payable | 17/49 | €78k |
| Amounts payable within one year | 42/48 | €78k |
| Trade debts payable within one year | 44 | €78k |
| Income statement | ||
| Gross operating margin | 9900 | €-15k |
| Operating result | 9901 | €-16k |
| Financial charges | 65 | €52 |
| Result before taxes | 9903 | €-16k |
| Net result for the period | 9904 | €-16k |
| Result to be appropriated | 9905 | €-16k |
This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2022 · computed22
/ 100
Critical
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2022. Indicative, not credit advice.
Structure & network
Locations & real estate
Registered office
from the Crossroads BankCannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Louizalaan 3791050 ElseneEstablishment units
1 locationTIBERONE TECHNOLOGIES
since 20212.327.442.150
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area702 m²
Buildings1
Building footprint743 m²
Volume (LiDAR)20,673 m³
Tallest building41.5 m · ±12 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21807G0211/00Y011 | Brussels | 702 m² | 1 · 743 m² | 41.5 m · 12 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgian State Gazette · acts
No structured acts for this company yet
That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.
Analysis
Financial profile
5 of 5 axes measured58
/ 100
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
Health
22
Profitability
100
Solvency
40
Growth
32
Stability
94
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector and regionBE 0465.717.883 · Elsene
BE 0424.462.496 · Elsene
BE 0419.658.523 · Elsene
BE 0533.705.678 · Elsene
BE 0502.513.349 · Elsene
We hold no filed accounts for this company, so a size comparison is not possible. These companies share only the sector and the region. We hold annual accounts for 2,267 of the 13,478 companies in this sector.
Company registry
Company registry (CBE)
Crossroads BankActivities
Adviesbureaus op het gebied van public relations en communicatie70210Activiteiten van adviesbureaus op het gebied van public relations en communicatie73300Overige niet-gespecialiseerde detailhandel47120Detailhandel via postorderbedrijven of via internet47910Webportalen63120Activiteiten van webportalen63910Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220
Primary activity highlighted.
Names & trade names
| Legal nameFR | TIBERONE TECHNOLOGIES |
Registered office
Louizalaan 379 bus 21
1050 Elsene, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.